structural mechanism sti- inhibition abelson tyrosine kinase 
inadvertent activation abelson tyrosine kinase abl causes chronic myelogenous leukemia cml small-molecule inhibitor abl sti- effective treatment cml report crystal structure catalytic domain abl complexed variant sti- critic:al binding sti- adoption kinase inactive conformation centrally located "activation loop" phosphorylated conformation loop distinct active protein kinases well inactive form closely related src kinases results suggest compounds exploit distinctive inactivation mechanisms individual protein kinases can achieve high affinity high specificity 
